U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C26H28N6.4ClHO4
Molecular Weight 826.375
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N,N,N',N'-TETRAKIS(2-PYRIDINYLMETHYL)-1,2-ETHANEDIAMINE TETRAPERCHLORATE

SMILES

OCl(=O)(=O)=O.OCl(=O)(=O)=O.OCl(=O)(=O)=O.OCl(=O)(=O)=O.C(CN(CC1=NC=CC=C1)CC2=NC=CC=C2)N(CC3=CC=CC=N3)CC4=CC=CC=N4

InChI

InChIKey=JKBQPGLRYWUSND-UHFFFAOYSA-N
InChI=1S/C26H28N6.4ClHO4/c1-5-13-27-23(9-1)19-31(20-24-10-2-6-14-28-24)17-18-32(21-25-11-3-7-15-29-25)22-26-12-4-8-16-30-26;4*2-1(3,4)5/h1-16H,17-22H2;4*(H,2,3,4,5)

HIDE SMILES / InChI

Molecular Formula C26H28N6
Molecular Weight 424.5407
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClHO4
Molecular Weight 100.459
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

N,N,N',N'-TETRAKIS(2-PYRIDYLMETHYL)ETHYLENEDIAMINE (TPEN) is a heavy metal chelator with strong affinities for Zn2+, Fe2+, and Mn2+. TPEN inhibits lamin assembly, destabilizes nuclear architecture and may independently protect nuclei from apoptosis in vitro. TPEN prevents HIF-1alpha from interacting with CBP, so reducing expression of HIF-1alpha target genes. TPEN was able to pass through the blood-brain barrier and the neuronal membrane, leading to successful intracellular zinc chelation - zinc chelation could be a potentially effective way for ischemic stroke treatment. TPEN exhibits robust anti-tumor activity in vivo in colon cancer mouse xenografts. In vivo experiments show that TPEN-loaded, aptamer-targeted liposomes reduce tumor growth in a human prostate cancer xenograft model.

CNS Activity

Curator's Comment: Known to be CNS penetrant in rats. Human data not available.

Originator

Sources: DOI: 10.1002/hlca.19670500817

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Zinc modulates cytokine-induced lung epithelial cell barrier permeability.
2006-12
Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.
2006-10
Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function.
2006-09
Endothelial response to stress from exogenous Zn2+ resembles that of NO-mediated nitrosative stress, and is protected by MT-1 overexpression.
2006-09
Inhibition of cyclooxygenase-2 expression by zinc-chelator in retinal ischemia.
2006-09
Zinc is required for Fc epsilon RI-mediated mast cell activation.
2006-07-15
Zinc-dependent multi-conductance channel activity in mitochondria isolated from ischemic brain.
2006-06-21
The zinc chelator, N,N,N',N'-tetrakis (2-pyridylmethyl) ethylenediamine, increases the level of nonfunctional HIF-1alpha protein in normoxic cells.
2006-05-19
Flow cytometric measurement of labile zinc in peripheral blood mononuclear cells.
2006-05-15
Intracellular zinc release and ERK phosphorylation are required upstream of 12-lipoxygenase activation in peroxynitrite toxicity to mature rat oligodendrocytes.
2006-04-07
Selenium prevents diabetes-induced alterations in [Zn2+]i and metallothionein level of rat heart via restoration of cell redox cycle.
2006-03
Protective effect of zinc against ischemic neuronal injury in a middle cerebral artery occlusion model.
2006-02
Apoptosis may underlie the pathology of zinc-deficient skin.
2006-02
Cytosolic labile zinc: a marker for apoptosis in the developing rat brain.
2006-01
Apoptotic neuronal changes enhanced by zinc chelator--TPEN in organotypic rat hippocampal cultures exposed to anoxia.
2006
New example of a non-heme mononuclear iron(IV) oxo complex. Spectroscopic data and oxidation activity.
2005-12-12
Taurine and zinc modulate outgrowth from goldfish retinal explants.
2005-12
Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
2005-12
Comparative sensitivity of rat cerebellar neurons to dysregulation of divalent cation homeostasis and cytotoxicity caused by methylmercury.
2005-11-01
Dynamics of SNARE assembly and disassembly during sperm acrosomal exocytosis.
2005-10
Selective zinc sensor molecules with various affinities for Zn2+, revealing dynamics and regional distribution of synaptically released Zn2+ in hippocampal slices.
2005-07-27
Caspase-3 dependent cleavage and activation of skeletal muscle phosphorylase b kinase.
2005-07
ZINC-mediated gene expression offers protection against H2O2-induced cytotoxicity.
2005-06-15
N,N,N',N'-tetrakis(2-pyridylmethyl)-ethylenediamine improves myocardial protection against ischemia by modulation of intracellular Ca2+ homeostasis.
2005-06
Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein.
2005-05-10
Simultaneous detection of [metal(II)-tpen]2+ as kinetically inert cationic complexes using pre-capillary derivatization electrophoresis: an application to biological samples.
2005-05
Search of chemical scaffolds for novel antituberculosis agents.
2005-04
Acid-sensing properties in rat gastric sensory neurons from normal and ulcerated stomach.
2005-03-09
Mechanisms of apoptosis in human retinal pigment epithelium induced by TNF-alpha in conditions of heavy metal ion deficiency.
2005-03
Tetrakis(2-quinolinylmethyl)ethylenediamine (TQEN) as a new fluorescent sensor for zinc.
2005-02-07
TPEN attenuates hepatic apoptotic ischemia/ reperfusion injury and remote early cardiac dysfunction.
2005-01
Zinc has ambiguous effects on chromium (VI)-induced oxidative stress and apoptosis.
2005
Expression of apoptosis-related proteins in model of anoxia in vitro.
2005
The mammalian Zip5 protein is a zinc transporter that localizes to the basolateral surface of polarized cells.
2004-12-03
Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation.
2004-11-24
Measurement of presynaptic zinc changes in hippocampal mossy fibers.
2004-11-05
XAS characterization of end-on and side-on peroxoiron(III) complexes of the neutral pentadentate N-donor ligand N-methyl-N,N',N'-tris(2-pyridylmethyl)ethane-1,2-diamine.
2004-10-21
Development of a zinc ion-selective luminescent lanthanide chemosensor for biological applications.
2004-10-06
Fungal susceptibility to zinc deprivation.
2004-10
Actions of zinc at mature Golgi cell to granule cell synapses in cerebellum of rats and mice.
2004-08-26
Differential regulation of zinc efflux transporters ZnT-1, ZnT-5 and ZnT-7 gene expression by zinc levels: a real-time RT-PCR study.
2004-08-15
Peroxisome proliferator activated receptors alpha and gamma require zinc for their anti-inflammatory properties in porcine vascular endothelial cells.
2004-07
Hippocampal mossy fiber calcium transients are maintained during long-term potentiation and are inhibited by endogenous zinc.
2004-04-09
Evaluation, using targeted aequorins, of the roles of the endoplasmic reticulum and its (Ca2++Mg2+)ATP-ases in the activation of store-operated Ca2+ channels in liver cells.
2004-04
Unliganded human mutant alpha 7 nicotinic receptors are modulated by Ca2+ and trace levels of Zn2+.
2004-04
Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels.
2004-02-05
Divalent cations regulate acidity within the lumen and tubulovesicle compartment of gastric parietal cells.
2004-01
Depletion of endogenous zinc stores induces oxidative stress and cell death in human melanoma cells.
2004
Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling.
2003-12-10
Regulation of zinc homeostasis by inducible NO synthase-derived NO: nuclear metallothionein translocation and intranuclear Zn2+ release.
2003-11-25
Patents

Sample Use Guides

Rat: 5 or 15 mg/kg
Route of Administration: Intraperitoneal
Human DU145 prostate cancer cells were exposed to TPEN (5 uM, 6 h) in both normoxic and hypoxic (1% O2) conditions and the levels of HIF-1a protein were measured by Western blotting. TPEN dramatically increased the amount of HIF-1a in both normoxic cells and hypoxic cells.
Substance Class Chemical
Created
by admin
on Wed Apr 02 05:51:02 GMT 2025
Edited
by admin
on Wed Apr 02 05:51:02 GMT 2025
Record UNII
447DAN30LD
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TPEN PERCHLORATE
Preferred Name English
N,N,N',N'-TETRAKIS(2-PYRIDINYLMETHYL)-1,2-ETHANEDIAMINE TETRAPERCHLORATE
Systematic Name English
TPEN PERCHLORATE [MI]
Common Name English
1,2-ETHANEDIAMINE, N1,N1,N2,N2-TETRAKIS(2-PYRIDINYLMETHYL)-, PERCHLORATE (1:4)
Systematic Name English
1,2-ETHANEDIAMINE, N,N,N',N'-TETRAKIS(2-PYRIDINYLMETHYL)-, TETRAPERCHLORATE
Systematic Name English
Code System Code Type Description
MERCK INDEX
m11846
Created by admin on Wed Apr 02 05:51:02 GMT 2025 , Edited by admin on Wed Apr 02 05:51:02 GMT 2025
PRIMARY
PUBCHEM
139065867
Created by admin on Wed Apr 02 05:51:02 GMT 2025 , Edited by admin on Wed Apr 02 05:51:02 GMT 2025
PRIMARY
CAS
163088-76-4
Created by admin on Wed Apr 02 05:51:02 GMT 2025 , Edited by admin on Wed Apr 02 05:51:02 GMT 2025
PRIMARY
FDA UNII
447DAN30LD
Created by admin on Wed Apr 02 05:51:02 GMT 2025 , Edited by admin on Wed Apr 02 05:51:02 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE